-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
AbCellera Biologics Inc. annual and quarterly Amortization of Intangible Assets in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
- AbCellera Biologics Inc. Amortization of Intangible Assets for the quarter ending 31 Mar 2025 was $922,000, a 45% decline year-over-year.
- AbCellera Biologics Inc. annual Amortization of Intangible Assets for 2025 was $3,700,000, a 74% decline from 2024.
- AbCellera Biologics Inc. annual Amortization of Intangible Assets for 2024 was $14,300,000, a 23% increase from 2023.
- AbCellera Biologics Inc. annual Amortization of Intangible Assets for 2023 was $11,600,000, a 10% increase from 2022.